drugset / Trial / NCT01374633

Sevoflurane Sedation on Intra Cranial Pressure in Traumatic Brain Injury Patients

NCT01374633

NaSingle-groupOpen-labelTreatment

Summary

Main purpose of the study is to evaluate the effect of sevoflurane on intra cranial pressure (ICP) after traumatic brain injury. Patients admitted for traumatic brain injury equipped with ICP measurement will be sedated with sevoflurane via the Anaconda device during 12 hours. Sedation will be controlled with BIS.

Timeline

Start
2011-12
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sevoflurane Other / unclassified 6 ml Inhaled

Indications